(Press-News.org) Reston, Va. (October 1, 2012) – Determining the optimal treatment course and predicting outcomes may get easier in the future for patients with head and neck sqaumous cell carcinomas (HNSCCs) with the use of an investigational imaging agent. Research published in the October issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) imaging with 3'-deoxy-3'F-18-fluorothymidine (18-F-FLT) during treatment and early follow-up has the potential to predict therapeutic responses and identify patients needing close follow-up to detect persistent or recurring disease.
Typically, tumor response to therapy is monitored by assessment of tumor size change by anatomic imaging modalities. While several studies have shown that F-18-fluorodeoxyglucose (FDG) PET may be used to assess response, the agent may produce false-positive findings. Authors of the study "Usefulness of 3'-Deoxy-3'F-18-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer" sought to determine if F-18-FLT, a recently introduced imaging agent, would also be useful in predicting response to therapy for HNSCCs.
"In experimental models, reduced FLT uptake preceded reduced FDG uptake, suggesting that decreased cell proliferation precedes changes in glucose metabolism," noted Hiroshi Hoshikawa, MD, lead author of the study. "However, there are few clinical studies comparing FLT-PET and FDG-PET findings for radiotherapy."
In the study, 28 patients with HNSCCs underwent F-18-FLT and F-18-FDG PET imaging prior to treatment with radiation therapy, four weeks after the start of therapy and five weeks after the conclusion of therapy. Uptake of both of the agents was measured in primary and metastatic lesions.
During the radiation therapy, F-18-FLT uptake disappeared in 34 of 54 lesions (63 percent); the negative predictive value was 97 percent. F-18-FDG uptake also had a high negative predictive value (100 percent) during radiation therapy, but only nine lesions (16 percent) showed absence of FDG. In addition, the specificity and overall accuracy of F-18-FLT were significantly higher than F-18-FDG PET both during and after radiation therapy. These findings indicate that F-18-FLT PET is more useful for assessing early loco-regional clinical outcomes and helpful for avoiding unnecessary radical surgery.
"With the development of new molecular imaging agents, it's now up to clinical researchers to utilize them to assess the characteristics of malignant tumors and their therapeutic response to chemotherapy, radiotherapy and molecular targeting therapy," said Hoshikawa. "We hope that our findings will be helpful in understanding the significance of F-18-FLT-PET."
###
Authors of the article "Usefulness of 3'-Deoxy-3'F-18-Fluorothymidine PET for Predicting Early Response to Chemoradiotherapy in Head and Neck Cancer" include Takehito Kishino, Hiroshi Hoshikawa and Nozomu Mori, Department of Otolaryngology, Faculty of Medicine, Kagawa University, Kagawa, Japan; and Yoshihiro Nishiyama and Yuka Yamamoto, Department of Radiology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
PET predicts early response to treatment for head and neck cancer patients
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Radiology is front and center in health care reform
2012-10-01
AUGUSTA, Ga. – While it's leveling off, a decade of increased use of sophisticated, expensive, imaging studies has put radiologists and their specialty front and center in health care reform, says the chair of an academic radiology department.
That seemingly dubious distinction gives radiologists the chance to take a leadership role in reducing costs, optimizing utilization and improving patient care, said Dr. James V. Rawson, Chair of the Medical College of Georgia Department of Radiology at Georgia Health Sciences University.
Rawson and Dr. Ruth Carlos, Professor ...
Tobacco contains highly toxic compounds not regulated by law
2012-10-01
Researchers from the University of Alicante (Spain) have analysed ten brands of cigarettes and found that the concentrations of certain harmful and carcinogenic substances vary significantly from one brand to another. Until now legislation has not covered these compounds and only establishes limits for nicotine, tar and carbon monoxide. Scientists have also developed catalysts to reduce the harmful products in tobacco.
In accordance with current legislation, cigarette packets indicate the nicotine, tar and carbon monoxide concentrations in order to confirm that these ...
Camels give President Obama's Alzheimer's plan a lift
2012-10-01
Bethesda, MD—President Obama's national plan to fight Alzheimer's disease just got a lift thanks to a team of international researchers whose recent discovery may lead to enhanced imaging of and improved drug delivery to the brain. A research report appearing in The FASEB Journal, describes an entirely new class of antibody discovered in camelids (camels, dromedaries, llamas, and alpacas) that is able to cross the blood-brain barrier, diffuse into brain tissue, and reach specific targets. Having such antibodies, which are naturally available, may be part of a "game changer" ...
Therapeutic time window important factor for cord blood cell transplantation after stoke
2012-10-01
Putnam Valley, NY. (Oct. 1, 2012) – A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within 72 hours of the stroke.
Their study is published in the current issue of Cell Transplantation (21:6), now freely available on-line at: http://www.ingentaconnect.com/content/cog/ct/.
"Ischemic stroke is one of the most frequent causes of death and the most common reason for permanent disabilities in adults in ...
MRI images transplanted islet cells with help of positively charged nanoparticles
2012-10-01
Tampa, Fla. (Oct. 1, 2012) – In a study to investigate the detection by MRI of six kinds of positively-charged magnetic iron oxide nanoparticles designed to help monitor transplanted islet cells, a team of Japanese researchers found that the charged nanoparticles they developed transduced into cells and could be visualized by MRI while three kinds of commercially available nanoparticles used for controls could not.
The study is published in a recent special issue of Cell Medicine [3(1)], now freely available on-line at: http://www.ingentaconnect.com/content/cog/cm.
"Our ...
Low birth weight may increase risk for cardiovascular disease, kidney disease and diabetes
2012-10-01
Bethesda, MD— Being underweight at birth may have consequences above and beyond the known short-term effects says a research report published in the October 2012 issue of The FASEB Journal. The report shows that rats with a low birth weight have an increased long-term risk for developing cardiovascular disease, kidney disease, and diabetes. What's more, older females are at higher risk of developing high blood pressure before and during pregnancy, which in turn, may restrict growth in the womb, putting offspring at risk for being born at a low birth weight.
"Ensuring ...
Biological markers increase clinical trial success rate of new breast cancer drugs
2012-10-01
Using biological markers--genetic characteristics that are associated with some patients with breast cancer--can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research from the University of Toronto Mississauga.
"It's been increasingly difficult for pharmaceutical companies to bring new drugs to market," says Jayson Parker, a faculty member in the Department of Biology and medical biotechnology analyst at the University of Toronto. "On average, about 80 per cent of drugs fail at some point in the clinical trial process."
There ...
Genetically engineered immune system fights melanoma
2012-10-01
MAYWOOD, Il. - Loyola University Medical Center has launched the first clinical trial in the Midwest of an experimental melanoma treatment that genetically engineers a patient's immune system to fight the deadly cancer.
A batch of the immune system's killer T cells will be removed from the patient and genetically modified in a Loyola lab. Two genes will be inserted into the T cells so that they will recognize tumor cells as abnormal.
The patient will undergo high-dose chemotherapy to kill most of his or her remaining T cells. This will make room for the genetically modified ...
AGU journal highlights -- 1 October 2012
2012-10-01
The following highlights summarize research papers that have been recently
published in Geophysical Research Letters (GRL), Journal of Geophysical
Research - Solid Earth (JGR-B), Journal of Geophysical Research - Oceans
(JGR-C), and Water Resources Research (WRR).
In this release:
1. The pros and cons of trading water: A case study in Australia
2. Linking typhoon tracks with rainfall patterns and flood timing
3. Novel observations of currents and drag generated by a tsunami
4. More water stored along major rivers during El Nino years
5. Model suggests Earth ...
New insights on control of pituitary hormone outside of brain has implications for breast cancer
2012-10-01
PHILADELPHIA - The hormone prolactin is produced by the pituitary gland in the brain and then travels via the bloodstream to cells throughout the body, where it exerts multiple reproductive and metabolic effects, most notably on the breast where it is the master regulator of lactation. In recent years researchers have found that prolactin is also produced by some tissues outside the brain, however little is known about the functions of extra-pituitary prolactin or how its production is regulated in these tissues.
Now, the laboratory of Lewis A. Chodosh, MD, PhD, chair ...